Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Return on Capital Employed [ROCE] (2011 - 2024)

Updated

Oruka Therapeutics' Return on Capital Employed [ROCE] was -26.85% in Q2 2024, down 7.16 percentage points from -19.69% a year earlier and down 4.50 percentage points from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Return on Capital Employed [ROCE] (2011 - 2024) Analysis & Trends

For FY2023, Return on Capital Employed [ROCE] at Oruka Therapeutics came in at -18.32%, up 3.82 percentage points from FY2022.

  • Return on Capital Employed [ROCE] shows a five-year change of +73.91 percentage points (FY2018 to FY2023).
  • In earlier years, Return on Capital Employed [ROCE] was -22.13% in FY2022 (+17.18 pp), -39.32% in FY2021 (-1.73 pp), -37.59% in FY2020 (+48.49 pp) and -86.08% in FY2019 (+6.15 pp).
  • The Q2 2024 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +6.66 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2019 (a gain of 64.30 percentage points); the worst was Q4 2021 (a drop of 15.29 percentage points).
  • Per Business Quant data, ORKA's Return on Capital Employed [ROCE] in the three quarters before Q2 2024 was -22.36% (Q1 2024), -19.26% (Q4 2023) and -18.53% (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Oruka Therapeutics 5.31 Bn 3.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -26.85%
Mar 31, 2024 -22.36%
Dec 31, 2023 -19.26%
Sep 30, 2023 -18.53%
Jun 30, 2023 -19.69%
Mar 31, 2023 -22.07%
Dec 31, 2022 -24.70%
Sep 30, 2022 -33.03%
Jun 30, 2022 -36.13%
Mar 31, 2022 -36.84%
Dec 31, 2021 -35.77%
Sep 30, 2021 -31.52%
Jun 30, 2021 -25.26%
Mar 31, 2021 -22.01%
Dec 31, 2020 -20.47%
Sep 30, 2020 -19.54%
Jun 30, 2020 -62.96%
Mar 31, 2020 -78.51%
Dec 31, 2019 -69.91%
Sep 30, 2019 -67.23%
API Access

Oruka Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY